Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (46 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Franklin India Flexi Cap Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹179.19 |
| 26 Aug 2009 | ₹145.46 |
| 08 May 2011 | ₹187.40 |
| 17 Jan 2013 | ₹222.74 |
| 30 Sep 2014 | ₹323.00 |
| 11 Jun 2016 | ₹392.28 |
| 21 Feb 2018 | ₹494.61 |
| 04 Nov 2019 | ₹501.14 |
| 16 Jul 2021 | ₹740.40 |
| 28 Mar 2023 | ₹813.16 |
| 08 Dec 2024 | ₹1427.58 |
| 20 Aug 2026 | ₹1395.02 |
| Metric | Franklin Templeton · Regular NAV ₹1,620.73 Very High risk ★★★★☆ | Category median Flexi Cap Fund · 46 funds |
|---|---|---|
| -1.31% | +3.25% | |
| +12.78% | +13.01% | |
| +13.20% | +11.30% | |
| +12.78% | +12.76% | |
| +13.80% | +12.77% | |
| +10.96% | — | |
| +15.12% | +14.91% | |
| +14.72% | +14.39% | |
| +14.40% | +13.95% | |
| Risk | ||
| 13.42% | 14.17% | |
| 0.47 | 0.45 | |
| 0.64 | 0.61 | |
| -56.43% | -31.26% | |
| Nifty 500 | — | |
| +1.00% | +1.10% | |
| 0.91 | 0.97 | |
| 97.3% | 100.1% | |
| 91.0% | 93.5% | |
| 1.76% | 2.15% | |
| ₹18,941Cr | ₹4,325Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 7% | 33% | |
| R Janakiraman · 13.6y | — | |
| 03 Apr 2006 | — | |
| 57 | — | |
| 42.0% | — | |
| 4.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.